Follow Us
Portfolio company and Correlation Ventures news. Data-driven insights on the VC industry. It's all here.
12.03.25
Read
Angle Health: Announces $134 million Series B to grow its AI-driven healthcare benefits offerings
11.12.25
OnRamp: Announces $15M Series A Raise to Build the Future of AI-Powered Customer Engagement
07.25.25
Manticore Games: Unveils Out of Time multiplayer roguelike game
07.15.25
Blok: Raises $7.5M to Let AI Simulate Users Before Your Product Even Launches
05.01.25
dub: Raises $30M to Scale Copy-Trading and Transform Retail Investing
05.20.25
Neon: Databricks Agrees to Acquire Neon to Deliver Serverless Postgres for Developers + AI Agents
04.30.25
Trek Health: Announcing Their $11M Series A and Competitive Market Analysis
03.27.25
Correlation: “When One Window Closes, Another One Opens?”
03.04.25
Nervonik: Raises $13 Million in Series A Financing to Advance Next-Generation Peripheral Nerve Stimulation for Chronic Pain Relief
04.21.25
ROH: How Payments Became Hospitality’s Biggest Growth Opportunity — And Why ROH Just Secured $9.2M to Lead the Charge
01.28.25
Bridge: Choice Hotels International and Bridge Team Up to Provide Hotel Owners with Access to Affordable Financing Solutions
HockeyStack: Raises $20M for marketing analytics
01.16.25
Bonfire Studios: Announces debut game Arkheron after 8 years
11.22.24
Valora Therapeutics: Raises $30 Million Seed Financing from Top Investors to Transform Immunotherapy with a Novel Glyco-immune Checkpoint Platform
07.17.24
Correlation: “Does Greater Risk Equal Greater Return in U.S. Venture?”
01.08.24
Correlation: “The 80/20 Rule for U.S. Venture? Not Exactly.”
06.27.23
Correlation Ventures Announces the Close of its Third Fund and Additions to Partnership: Raising $130M for its latest venture capital fund, the firm now has approximately $500M under management
07.13.23
Correlation: “Venture Capital — We’re Still Not Normal”
04.25.23
Mirvie: Publication of the Preeclampsia Prevention Care Plan, the first-ever actionable, evidence-based care plan for the prevention of preeclampsia.
04.13.23
Candesant Bio: Announcing the FDA clearance of BRELLA™ SweatControlPatch™
Categories
